4//SEC Filing
Sirtris Pharmaceuticals, Inc. 4
Accession 0001179110-08-001542
CIK 0001388775operating
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 11:57 AM ET
Size
48.0 KB
Accession
0001179110-08-001542
Insider Transaction Report
Form 4
Jirousek Michael
Senior VP, Research
Transactions
- Sale
Common Stock
2008-01-22$12.36/sh−859$10,617→ 46,621 total - Sale
Common Stock
2008-01-22$12.40/sh−265$3,286→ 45,856 total - Sale
Common Stock
2008-01-22$12.13/sh−140$1,698→ 52,060 total - Exercise/Conversion
Incentive Stock Option (Right to Buy)
2008-01-22−20,000→ 151,429 totalExercise: $1.10Exp: 2016-08-30→ Common Stock (20,000 underlying) - Sale
Common Stock
2008-01-22$12.11/sh−100$1,211→ 52,200 total - Sale
Common Stock
2008-01-22$12.34/sh−487$6,010→ 48,500 total - Sale
Common Stock
2008-01-22$12.17/sh−400$4,868→ 51,660 total - Sale
Common Stock
2008-01-22$12.26/sh−309$3,788→ 50,737 total - Sale
Common Stock
2008-01-22$12.33/sh−500$6,165→ 48,987 total - Sale
Common Stock
2008-01-22$12.28/sh−250$3,070→ 50,287 total - Sale
Common Stock
2008-01-22$12.35/sh−820$10,127→ 47,680 total - Sale
Common Stock
2008-01-22$12.39/sh−300$3,717→ 46,121 total - Sale
Common Stock
2008-01-22$12.46/sh−982$12,236→ 43,553 total - Sale
Common Stock
2008-01-22$12.06/sh−200$2,412→ 52,300 total - Sale
Common Stock
2008-01-22$12.41/sh−421$5,225→ 45,435 total - Award
Common Stock
2008-01-22$1.10/sh+20,000$22,000→ 52,500 total - Sale
Common Stock
2008-01-22$12.23/sh−114$1,394→ 51,146 total
Footnotes (2)
- [F1]Sale was effected pursuant to a Rule 10b5-1 Trading Plan previously entered into by Reporting Person.
- [F2]The options vested as to 25% of the shares on August 30, 2007, with the remainder vesting in equal quarterly installments until August 30, 2010.
Documents
Issuer
Sirtris Pharmaceuticals, Inc.
CIK 0001388775
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001388775
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 11:57 AM ET
- Size
- 48.0 KB